Core conditions Flashcards

1
Q

What is diverticular disease?

  • pathology
  • RF
  • Clinical features
  • Investigations
  • Treatment
  • Complications
A

PATHOLOGY

  • High intraluminal pressures force mucosa & submucosa to herniate through muscle layers of gut at weak points, adjacent to penetrating vessels (where vasa recti penetrate the colonic wall)
  • Most within sigmoid colon (95% complications at this site)
  • Can affect small or large bowel
  • repeated attacks of inflammation –> thickening of bowel wall, narrowing of lumen - eventual obstruction

RF

  • Low fibre diet
  • age >50

CLINICAL FEATURES

  • majority asymptomatic
  • altered bowel habit (usually constipation) + left iliac fossa/ colicky pain (relieved on defecation)
  • nausea & vomiting
  • sigmoid colon may be palpable

INVESTIGATIONS

  • CT abdomen - especially if acute (colonoscopy may cause perforation in acute diverticulitis), confirm diagnosis, assess severity, show complications?

TREATMENT

  • Bowel rest
  • antibiotics may be needed (given by GP or in hospital, may need to be IV)
  • treatment of constipation
  • Surgery

COMPLICATIONS

  • bleeding
  • segmental colitis
  • perforation
  • abscess
  • fistulas
  • obstruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is coeliac disease?

A
  • Common digestive condition – 1 in 150-300; 1% in UK
  • Females 2x as often as males
  • Peak in infancy after initial exposure to gluten, larger peak in 40-50s
  • Inflammatory disorder of small bowel
  • Hypersensitivity reaction to glutamine-rich proteins in wheat, barley & rye (gliadins, hordeins, secalins) NOT allergy/intolerance
  • Gluten = specific peptide fraction of protein
  • Autoimmune condition → damage to lining villi of small intestine.
  • Strong link to certain HLA class II genes (HLA-DQ2 [95%] and HLA-DQ8)
  • However most DQ2/DQ8 +ve people never develop coeliac
  • Villi increase absorptive surface & have blood vessels to absorb nutrients. 

  • Damaged→ malabsorption (Vits, minerals, calcium, carbohydrates, protein, fats)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Symptoms of coeliac

A

Variable

  • Lethargy – tired all the time
  • Anaemia (Fe, folate, B12 and mixed)
  • Malabsorption
  • Abdominal pain
  • Non-specific abdominal symptoms (bloating)
  • Diarrhea
  • Weight loss
  • Oral ulceration
  • Osteoporosis
  • Sub-fertility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diagnosis of coeliac

A

(1) IgA-tTG
- consider IgG tests if IgA deficient
(2) biopsy from 2nd part of duodenum
- at least 4 biopsies taken and one from duodenal bulb

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Histological features of coeliac

A
  • chronic inflammation
  • villous atrophy
  • crypt hyperplasia
  • decreased villi to crypt ratio
  • loss of enterocyte height
  • lamina propria infiltration
  • increased intra-epithelial lymphocytes
  • Increased mitotic activity
  • epithelial damage
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the treatment for coeliacs disease?

A
  • gluten free diet (avoid wheat, rye and barley - oats probably okay)
    if non-responsive - consider prednisolone (7.5-20mg)
  • or immunomodulator (AZA)
  • Check for common deficiencies
    GIVE Calcium and Vitamin D.
    Fe only given if deficient.

Bone mineral density should be done for baseline. Re-evaluate 1 year after starting gluten free diet.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Conditions associated with coeliac

A

Range of extra-intestinal conditions

  • Endocrine – Type 1 diabetes, thyroid disorders
  • Liver – primary biliary scleorosis, autoimmune hepatitis
  • Skin – dermatitis herpetiformis
  • Neruological
  • Cardiac
  • IgA deficiency

  • SBBO – small bowel bacterial overgrowth
    8% non-responsive coeliac patients
    Symptoms: Diarrhea, pain, weight loss, bloating, flatulence, nausea, steatorrhoea
    Nutritional deficiencies - Vit D (tetany), Vit A (night blindness), Cobalamin (neuropathy), VitB12 (macrocytosis)
    Investigation: H2 Lactose / Glucose breath test
    Treatment: 7-10/7 course of
    • CO-amoxiclav + metronidazole
    • Cephalexin + co-trimoxazole
    • Gentamicin + metronidazole

Hyposplenism

  • 80%
  • Howell Jolly bodies, target cells, thrombocytopenia
  • Treatment:
    • Meningococcal, pneumococcal, HIB vaccinatinos
    • Prophylactic antibiotics
    • ALL patients with new diagnosis of coeliac require annual flu vaccines and also pneumococcal vaccine

Autoimmune conditions
- Thyroid disease, Type 1 diabetes, addison’s, Sjogrens syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is dermatitis herpetiformis?

A

Patches of intensely itchy blisters on elbows, knees, back, buttocks

  • 2-3% of people with coeliac have it
  • IgA deposition at basement membrane

Treatment:
Gluten free diet
In some can try: Dapsone (100-150mg daily)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Peptic ulcer disease

  • what is it?
  • what is the prevalence?
  • gender preference?
  • other RF
A

Ulcer in oesophagus and/or stomach and/or duodenum

Affects 10% of population

M>F = 5:1

Commonest in blood group A
family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Duodenal ulcers

  • RF
  • diagnosis
A

4x commoner than gastric ulcer

RF: helicobacter pylori, drugs (NSAID, steroids, SSRI), increased gastric acid secretion, increased gastric empyting, smoking

Diagnosis: Upper GI endoscopy; Test for H pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Gastric ulcers

  • RF
  • diagnosis
A

mainly in elderly on lesser curve

RF
H pylori
smoking
NSAIDs
reflux of duodenal contents
delayed gastric emptying
stress

Diagnosis: Upper GI endoscopy, multiple biopsies. Repeat endoscopy after 6-8 weeks to confirm healing and exclude malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of peptic ulcer disease

A

H. pylori (>90% duodenal ulcers, >70% gastric ulcers)
- If <55 years old – test & treat

NSAIDs – deplete mucosal defence

Stress – burn injury, sepsis, prolonged hospitalisation

Smoking – causes increased risk/ delayed healing

Familial predisposition
- ?HP cluster? Genetic?

Rare
- Acid-pepsin versus mucosal resistance
Zollinger Ellison syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Zollinger-Ellison syndrome

  • What is it?
  • Features?
A

Gastric acid hyper secretion due to a gastrin secreting tumour of islet cell of pancreas
- Leads to peptic ulceration

2/3 malignant but slow growing

20-60% have co-existing adenomas of parathyroid and pituitary (MEN-1)

Gastrin hypersecretion → hyperacidity and ulcers

Pancreatic enzymes inactivated due to low pH & bile salts precipitate causing diarrhoea & steatorrhoea

Features

  • Multiple ulcers often unusual sites
  • Poor response to standard therapy
  • Complications common
  • Diarrhoea can be presenting feature
  • Serum gastrin levels grossly elevated / secretin stimulation further increases levels

Tumour localisation difficult
- CT; Selective angiography and sampling; EUS

Management

  • Surgical resection if tumour localised
  • PPI’s high dose
  • Octreotide injections to reduce gastrin levels

5y survival 60-75%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Peptic ulcer disease

- symptoms

A

Often difficult to differentiate from gastric cancer

  • Epigastric pain (relief by food)

Duodenal

  • Several hours post-prandially or awakened the patient from sleep or both
  • “pain decreases with food” - Often eating food seems to help “feed the ulcer”

Gastric ulcers

  • Pain felt shortly after meals and eating food does not stop pain “pain greater with eating”
  • Dyspeptic constellation & bloating
  • No symptoms – silent ulcers common in elderly & may be NSAID induced
  • NO specific signs i.e epigastric tenderness
Nausea
Fullness
Bloating
Hunger pain
Heartburn (retrosternal pain)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Alarm symptoms of peptic ulcer disease

A

Vomiting
Pain radiation
Early satiety
Nocturnal pain

Sinister symptoms → malignancy

Vomiting (?gastric outlet obstruction)

Pain radiation = pancreatic pathology

A - anaemia
L - loss of weight
A - anorexia
R - recent onset/progressive symptoms
M - malaria/haematemesis
S - swallowing difficulty
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Peptic ulcer disease investigations

A

Endoscopy - take biopsy from raw edges of ulcer

Barium meal examination

H. Pylori status

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Peptic ulcer disease management

A

Stop smoking; Avoid aspirin, NSAIDs; Alcohol in moderation

Depends on cause: H pylori / NSAIDs

Maintenance treatment

  • Not necessary after successful helicobacter pylori eradication
  • If cannot avoid NSAIDs or aspirin may require long term protection

Medications: Short-term awaiting HP status - PPI

Bleeding 
- 30-50% due to peptic ulcer
- Mortality remains 6-10%
- Haematemesis, malaena
Treatment:
- IV access
- Define circulatory status&amp; co-morbidity
- Blood tests: FBC, U&amp;Es, LFTs
- Cross-match blood 
- Resuscitation – crystalloids, colloids, blood
- Intensive monitoring
- Early endoscopy
- HP eradication
- PPIs 
- Surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Peptic ulcer disease surgical management

  • emergency
  • elective
A

Emergency

  • Perforation of ulcer (more common in duodenal)
  • Peritonitis, shock
  • Sudden severe pain initially in upper abdomen then generalised; Shoulder tip pain (irritation of diaphragm)
  • Air under diaphragm (bilateral)
  • Absent bowel sounds
  • Mortality 10%
  • Bleeding (that cannot be controlled endoscopically)

Elective

  • Chronic non-healing gastric ulcer
  • Partial gastrectomy
  • Complications of surgery: dumping (rapid gastric empyting), bile reflux gastropathy, diarrhoea, maldigestion,

Gastric outflow obstruction

  • Nausea, vomiting of previously eaten food, abdominal distension
  • Visible gastric peristalsis, succession splash, dehydration
  • Management: IV fluids, correction of acidosis, nasogastric suction, endoscopy

Recurrent ulcer following surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Signs of ulcer perforation

A
  • Peritonitis, shock
  • Sudden severe pain initially in upper abdomen then generalised; Shoulder tip pain (irritation of diaphragm)
  • Air under diaphragm (bilateral)
  • Absent bowel sounds
  • Mortality 10%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

H pylori

- where does it cause ulcer most often?

A

Duodenal > gastric

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

H pylori

- long term consequences

A

Gastric cancer
gastric-marginal B cell lymphoma (MALT)
non-ulcer dyspepsia
NSAID induced gastropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

H pylori

- what kind of bacteria is it

A

Spiral shaped gram –ve acidophilic bacterium

4-6 flagella - multiple sheathed flagella

Strong urease activity

Shape, motility & enzymatic action → penetrate beneath mucosal layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

H pylori

  • Epidemiology
  • For who is probability of being infected greater?
A

Associated with lower economic status – rather than race

Probability of being infected is greater:

  • For older persons (>50 years)
  • Minorities (African-Americans 40%)
  • Immigrants from developing countries (Latino, Eastern Europe)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

H pylori

- pathology

A

Oral transmission
Stomach colonisation
Lives next to epithelium
- Prefers antrum - if H+ secretion very high
- Protected by stomach mucus & ability to produce urea to buffer acidic pH

Provokes inflammatory response releasing cytokines

  • Vacuolating cytotoxin (vacA) – formation of vacuoles, induction of apoptosis, disruption of epithelial junctions, blockage of T cell response
  • Cytotoxin-associated gene (cagA) – alteration of signalling pathways, alteration of tight junctions

Adhesins – attachment to epithelial cells

LPS – induction of inflammatory response

Urease – Urea → NH3 + CO2.
- Ammonia provides a neutral microenvironment favourable to H. pylori

Antral stomatostatin is depleted and increased gastrin release by G cells

Hyperacidity occurs with mucosal damage

Duodenum develops gastric like tissue (metaplasia) with further colonisation and hyperacidity

Depletion of antral D-cell somatostatin

Increased gastrin release from G cells

Increased acid secretion

Increased acid load in duodenum leads to gastric metaplasia

Inflammation & eventual ulceration

May lead to glandular atrophy of gastric mucosa and intestinal metaplsia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

H pylori

- 3 mechanisms of injury

A

Hypergastrinemia
- Negative feedback for gastrin is blocked – resulted in uncontrolled excess gastrin → hyperacidity

Direct mucosal injury
- Cytotoxins cause increased production of ammonia (toxin to epithelial cells)

Inflammatory response
- Mediated by macrophages, neutrophils, T-cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

H pylori

- diagnosis

A

Non-invasive testing

  • Breath test
  • Antibody measurement (serology)
  • > Tells you that in some point have been in contact with helicobacter
  • Stool HP antigen test

Invasive

  • Culture - used if want antibiotic sensitivity
  • Histology
  • Urease (CLO) test
  • > Changes to red (high pH due to ammonia)
  • > Used bedside at endoscopy
27
Q

H pylori

  • treatment
  • SE
A
1st line (90% efficacy)          
Triple therapy for 1 week

PPI - Lansoprazole 30mg 2x daily (or omeprazole 20mg BD)
Clarithromycin 500mg 2x daily
Metronidazole 400mg 2x daily

2nd line (85-90% efficacy) - 1 week

  • Lansoprazole 30mg 2x daily (or omeprazole 20mg BD)
  • Clarithromycin 500mg 2x daily
  • Amoxycillin 1g 2x daily

Eradication not always necessary / eradication may cause regression of some gastric lymphomas – MALTomas

SE: diarrhoea (30-50% - mild, C difficile colitis can occur),

Amoxicillin: penicillin-sensitivity rash, diarrhoea

Clarithromycin: GI upset, enzyme inhibitor

Metronidazole: metallic taste, flushing/vomiting if taken with alcohol, nausea, vomiting, abdominal cramps, headaches, rash

28
Q

NSAID induced peptic ulcer disease

  • pathology
  • RF
  • treatment
A

Tissue injury → release of phospholipids → arachidonic acid
- Leukotrienes (bronchoconstriction)
- Cox-1 (constitutional)
Cytoprotective prostaglandins -> Protective for gastric mucosa lining; Aid platelet aggregation
- Cox -2 (inducible) - Recruit inflammatory white cells; Sensitize skin pain receptor; Stimulate hypothalamic fever response

All NSAIDs also inhibit COX-1 → increase risk of developing ulcers due to reduced protection from acid

Prostaglandins stimulate bicarbonate and mucus secretion and increase mucosal blood flow

RF

  • Age >60 y/o (atrophic gastritis)
  • Past history of peptic ulcer disease
  • Past history of adverse events with NSAIDs
  • Concomitant corticosteroid use
  • High dose or multiple NSAIDs
  • Individual NSAID – lower with ibuprofen

Treatment

  • Offending drug should be removed
  • NSAIDs should be used at lowest effective dose
  • Co-prescription of a PPI will heal most ulcers
  • Prescription of a COX-2 specific drug will limit GI toxicity -> Celecoxib
29
Q

Diverticular disease DD

A
colorectal cancer
ischaemic colitis
appendicitis
IBD
Infection
30
Q

What is the function of the pancreas?

A

Exocrine – digestive function – releases juices into ducts
- Trypsin & chymotrypsin → proteins
- Amylase → carbohydrates
- Lipase → fats

Endocrine – releases hormones into blood; regulates blood sugar

31
Q

Congenital abnormalities of the pancreas

A

Pancreas divisum (a single pancreatic duct has not formed – remain as two distinct: dorsal and ventral)

Annular pancreas (ring of pancreatic tissue continuous with head of pancreas surrounds 2nd part of duodenum → constriction)

32
Q

What is acute pancreatitis?

- pathology

A

Acute inflammatory process of the pancreas - variable involvement of other regional tissues/ remote organ systems

Epidemiology: 40/100,000; 3% of all admissions with abdominal pain

Mild: Minimal organ dysfunction; Uneventful recovery

Severe: Organ failure and/or local complication; Necrosis

Pathology

  • Premature intracellular trypsinogen activation → proteases released and digest pancreas
  • Nuclear factor kappa activated → mitochondrial dysfunction, autophagy, inflammatory response
33
Q

Aetiology of pancreatitis

A

I Get Smashed

I - idiopathic
G – gall stones
E – ethanol
T – trauma

S – steroids
M – mumps
A – Autoimmune
S – scorpion bite
H – hypoglycaemia, hypocalcaemia
E – ERCP
D – dehydration; drugs

Idiopathic; Gall stones; Ethanol; Trauma; Steroids; Mumps; Autoimmune; Scorpion bite; ERCP; vascular disease hypothermia

Hypoglycaemia, hypocalcaemia, hyperparathyrodism

Dehydration; drugs - Furosemide; didanosine; oestrogens; azathioprine, thiazide diuretics; sulphonamides; tetracyclines; sulindac; mercaptopurine

Malignancy –periampullary cancer

34
Q

Acute pancreatitis presentation

A
  • Variable

Severe abdominal pain radiating to back
- Relieved when lean forward; worse with movements

Associated with vomiting, nausea, fever, tachycardia

Organ failure – respiratory, renal; ARDS

Jaundice, cholangitis

Grey Turner’s sign (bruising of flanks → retroperitoneal bleeding)

Cullen’s sign (bruising around umbilicus due to liberated pancreatic enzymes →diffusion of fat necrosis and inflammation with retroperitoneum or intraabdominal bleeding)

35
Q

Grey Turner’s sign

A

bruising of flanks → retroperitoneal bleeding

36
Q

Cullen’s sign

A

bruising around umbilicus due to liberated pancreatic enzymes →diffusion of fat necrosis and inflammation with retroperitoneum or intraabdominal bleeding

37
Q

Acute pancreatitis diagnosis and investigations

A

Age – 40-50 years; Epigastric tenderness

Exam

(1) In early stages – guarding & rebound tenderness absent as inflammation principally retroperitoneal
- -> Opposite to perforated peptic ulcer
(2) Bowel sounds may becomes absent → paralytic ileus

Determine cause
- Gallstones; alcohol; medications; FH; viral illness

Initial:
- Pancreatic enzymes (amylase, lipase) – 3-4 times elevated serum amylase
elevated - Supports but is not pathogonomic
- LFTs
- US of gallbladder and biliary tree

2nd line

  • Fasting plasma lipids
  • Fasting plasma Calcium (after acute episode)
  • Viral antibody titres
  • Autoantibody / IgG4 titres
  • MRCP / CT scan of pancreas

3rd line

  • Repeat gallbladder US
  • Endoscopic US
  • ERCP (bile for crystals)
  • Sphincter of oddi manometry
38
Q

DD of acute pancreatitis

A

Biliary colic
perforated peptic ulcer - will have guarding and rebound tenderness
Acute mesenteric ischaemia, Acute MI
Basal pneumonia

39
Q

What is the prognosis of acute pancreatitis?

A

80% resolve spontanously

20% develop complications

40
Q

Acute pancreatitis treatment

A

Supportive treatment

Fluid resuscitation
IV crystalloids (Ringer’s lactate)
Analgesia
- Morphine sulphate IV; fentanyl; ketorolac
Correct electrolyte abnormalities
Nutrition
Nil by mouth initially if vomiting; Feeding; 
Dietician
Monitor early warning signs
Organ dysfunction
Critical care support 
? antibiotics - not given unless there is actual inflammation of the pancreas due to bacteria!! if cause is gallstones, do not give antibiotics!
41
Q

Acute pancreatitis - surgery options and indications

A

Surgery

  • Doubt in diagnosis
  • Early cholecystectomy if have gallstones
  • ERCP
Acute cholangitis
Jaundice dilated bile duct on US
Necrosectomy -> MIRP / Open
Bleeding
Pancreatic abscesses
Pancreatic pseudocyst
42
Q

Possible complications of acute pancreatitis

A
Local
- Peripancreatic fluid collection 
- Pancreatic necrosis; abscess 
- Infected necrosis 
→ May lead to shock
Treatment: carbapanems, quinolones, metronidazole 

Pseudocyst 

- May be caused by inflammation of parenchyma

Biliary/gastric obstruction 


General

  • Respiratory failure; Renal failure; Circulatory failure
  • Malnutrition
43
Q

Acute pancreatitis death rates

A

Two peaks in death rates – Early death - 1st week / late death - 2nd week

Week 1 – Initial attack → SIRS → MODS
-Death due to multi-organ system failure

Week 2- Pancreatic necrosis → sepsis → MODS
- Death due to infected pancreatic necrosis

44
Q

Acute pancreatitis - Glasgow criteria for prognosis

A

> 3 = severe disease

P- PaO2 <8 kPa (60mmHg)
A- Age (>55)
N- Neutrophils (WCC >15x10^9/L)
C- Calcium (decreased Ca = severe/ increased Ca may have caused pancreatitis)
R- renal function (urea >16mmol/L)
E- enzymes (delayed LFTs)  alanine aminotransferase >200U/L
A- albumin
S – sugar (high BM)  >10mmol/L

+ lactate dehydrogenase

45
Q

Chronic pancreatitis

  • what is it?
  • symptoms?
A

12/100,000

Continuing inflammatory disease of pancreas - irreversible, morphologic change that typically causes pain or permanent loss of function or both

Progressive; Inflammatory change, necrosis, fibrosis

Symptoms
Loss of exocrine and endocrine elements
Epigastric pain that bores through to the back
Relieved by sitting forward; hot water bottle (epigastrium /back)
Bloating; steatorrhoea
Reduced weight

Symptoms relapse and worsen

46
Q

Causes of chronic pancreatitis

A

TIGARO

T= toxic-metabolic
- Alcohol; tobacco; hyperCa, chronic kidney disease

I = idiopathic
- Tropical/ early or late onset types

G = genetic

  • Hereditary pancreatitis (cationic trypsinogen mutation)
  • SPINK-1 mutatino
  • Cystic fibrosis
  • Haemochromatosis (iron builds up in body)

A = auto-immune
- Consider in older patients

R = recurrent and severe acute pancreatitis
- Reccurent; post-necrotic

O = obstructive

  • Ductal adenocarcinoma
  • Intraductal papillary mucinous neoplasia
  • Pancreas divisum
  • Sphincter of Oddi stenosis
47
Q

Chronic pancreatitis investigations

A

Nutritional assessment
- Clinical; Anthropometry; Biochemistry

Morphology of pancreas
(1) US + CT scan
CT – pancreatic calcifications, enlargement, ductal dilation

MRCP/ MRI pancreas; ERCP

Pancreatic function tests

  • Collect pure pancreatic juice after secretin injection – invasive & seldom used
  • Endocrine - May have elevated blood glucose/ diabetes occurs in advanced cases

Exocrine: Direct; Indirect

48
Q

Direct testing of exocrine function of pancreas

A

Secretin stimulation tests

49
Q

Indirect testing of exocrine function of pancreas

A

Faecal elastase, pancreolaurlyl

50
Q

Chronic pancreatitis treatment

A

Analgesia
- Coeliac-plexus block

Lipase (Creon)

Insulin needs may be high/variable – beware hypos

Identify cause

Alcohol counselling

Dietician – nutritional supplements
Fat soluble vitamins
No alcohol; low fat

Role

  • Relieve symptoms – pain
  • Treat complications – obstruction (biliary/gastric), pseudocyts, pseudo-aneurysm

PPI may be given optimise duodenal pH for pancreatic enzyme activity

Surgery
Decompression of pancreatic/bile duct
- Peustow’s lateral pancreatico-jejunostomy
- Hepatico-jejunostomy

Resectional surgery


  • Whipples pancreatico-duodenectomy
  • Distal pancreatectomy

Combined


  • Frey’s surgery

  • Beger’s procedure
51
Q

Auto-immune pancreatitis

  • presentation
  • lab results
  • CT results
A

Form of chronic pancreatitis

Mimic cancer but responds to glucocorticoids
- Some may require azathioprine

Abdo pain, weight loss or obstructive jaundice

NO acute attacks of pancreatitis

Increased serum IgG or IgG4

Diffusely enlarged pancreas, narrowing of pancreatic duct, structuring of lower bile duct

52
Q

Pancreatic carcinoma

  • RF
  • pathology
  • symptoms
  • examination
  • diagnosis
  • treatment
  • prognosis
A

600-700/year in Scotland

Late presentation
Typically male (2:1) , >70 years old

RF: smoking, alcohol, carcinogens, DM, chronic pancreatitis, increased waist circumference

Pathology

  • Mostly ductal adenocarcinoma (metastasize early, present late)
  • 60% pancreas head; 25% body; 15% tail
  • 95% mutation in KRAS2 gene
Symptoms
Non-specific abdominal symptoms
Epigastric pain radiating to back 
Obstructive jaundice
Weight loss, anorexia
May have diabetes or acute pancreatitis 

Exam:
- May have epigastric mass, hepatomegaly, splenomegaly, lymphadenopathy, ascites

Diagnosis

  • Bloods: Cholestatic jaundice
  • US / CT

Staging – CT abdomen & chest +/- laparoscopy

Treatment
Resection
- Pancreatoduodenectomy/Whipple’s – head of pancreas, duodenum, portion of stomach removed

Chemotherapy
- Post-op – delays progression

Prognosis
Dismal – mean survival <6 months; 5 year survival 3%

53
Q

Pancreatic exocrine insufficiency

A

Pancreas produces 1.5L/day of bicarbonate and enzyme-rich fluid (digestion of fat, protein, carbohydrate)

Lipolytic activity declines first so fat absorption mainly affected

Steatorrhoea, weight loss, vitamin deficiency (A,D,E,K)

Causes: chronic pancreatitis, pancreatic cancer, CF, haemachromatosis, pancreatic resection, gastric resection

Treatment: pancreatic enzyme replacement, taken with meals and snacks, gastric acid suppression (supplements work at higher pH), vitamin supplements

54
Q

Small bowel overgrowth (SIBO)

  • causes
  • treatment
A

Causes (1) Stasis: strictures (Crohns, TB), Hypomotility (Old age, opiate analgesics, diabetes, systemic sclerosis) (2) Blind loops, diverticulae (3) Immunodeficiency

Treatment: 2 weeks antibiotics

55
Q

Bile acid malabsorption

A

Bile acids absorbed in ileum → cause secretory diarrhoea in colon

Type 1 – ileal disease or resection
Type 2 – idiopathic
Type 3 – assoc. with cholecystectomy, rapid transit, coeliac, SIBO, chronic pancreatitis

Investigation: Serum 7-alpha cholestenone

Treatment: cholestyramine, colesevelam

56
Q

Giardia lamblia

A

Non-invasive pathogen

Malabsorption due to brush border damage; reduction in absorptive surface; bile acid utilization; induction of hypermotility; enterotoxin

Treatment: metronidazole

57
Q

Causes of malabsorption

A
Coeliac disease
Pancreatic exocrine insufficiency
Small bowel overgrowth
Bile acid malabsorption
Giardia lamblia
58
Q

Functional dyspepsia

  • clinical features
  • Important points to consider
  • investigations
  • management
A

Chronic dyspepsia in absence of organic disease
-May have early satiety, fullness, bloating, nausea

Cause poorly understood – probably mucosal, motility, psychiatric disorders

Clinical features

  • Usually young <40 years; W:M, 2:1
  • Abdominal discomfort with other dyspeptic symptoms
  • Nausea, satiety, bloating after meals
  • Morning symptoms are characteristic, pain, nausea may occur on waking
  • History - may have symptoms of IBS
  • Inappropriate tenderness on abdominal pain
  • NO weight loss
  • Symptoms may be disproportionate to clinical well-being

Must consider:

  • Peptic ulcer disease
  • Intra-abdominal malignancy – older people
  • Depressive illness?
  • Alcohol misuse – early-morning nausea, retching

Investigations

  • Rule out pregnancy before radiological investigations!
  • Check for H. pylori infection -> Offer treatment if +ve ; SE: worsening of underlying GORD
  • > 55 years old – endoscopy to exclude mucosal disease

Management

  • Explanation and reassurance
  • Explore psychological factors
  • Idiosyncratic and restrictive diets little benefit – but may try smaller portions, fat restriction

Drugs
- Antacids sometimes helpful - hydrotalcite
- Prokinetic drugs
Metoclopramide (SE: extrapyramidal – tardive dyskinesia in young patients), domperidone
Given before meals if nausea, vomiting, bloating prominent
H2 –receptor antagonist
- If night pain or heartburn

Low dose tricyclic agents

59
Q

Functional bowel disease

A

Persistent & unexplained symptoms - no structural abnormality/ pathological process

Disordered physiological function
- Attributable to mid or lower GI tract

Peak in 20-40 year olds
Mainly female = 3:1

Coexisting conditions common: non-ulcer dyspepsia, chronic fatigue syndrome, dysmenorrhoea, fibromyalgia

60
Q

Causes of functional bowel disease

A

Likely multifactorial: Chemical / stress/ hormonal changes / food / genetic / infection / anxiety / medications / depression / trauma – panic disorder

May be state of low-grade gut inflammation/immune activation, not detectable by tests

  • Raised number of mucosal mast cells that sensitise enteric neurones by releasing histamine and tryptase
  • Some respond to Ketotifen – mast cell stabiliser

Post infective IBS

  • 6-17% - onset of symptoms attributed to acute gastroenteritis episode
  • Salmonella; Campylobacter
  • 25% continue with altered bowel habits (6 months post episode)
  • Hypotheses: Increased response to inflammatory stimuli

Emotional factors

  • Psychological factor – 80%
  • Previous depressive illness – 40%; Current psychiatric illness – 70%
  • Sometimes associated with history of physical/sexual abuse
  • BENEFIT from psychologically based therapy

Physiological factors: Serotoninergic disorder – increased release of 5-HT in D-IBS & deficiency in constipation-predominant diarrhoea

Luminal factors
- SIBO – gut dysbiosis present in some
Respond to probiotics & non-absorbable antibiotic - rifaximin (for C-IBS)
- Chemical food intolerance to poorly absorbed, short-chain carbohydrates (lactose, fructose and sorbitol) – fermentation in colon leads to bloating, pain, wind and altered bowel habits.

Dysfunction with motor & sensory aspects – altered gut reactivity (motility and secretion) in response to stimuli, may be environmental, or luminal

61
Q

Enteric nervous system

A

Controls intestinal motility & secretory functions

Semi-autonomous
- Parasympathetic (cholinergic) and sympathetic NS (adrenergic)

Functions independently

Contains many neurotransmitters – including 5-hydroxytryptamine (5-HT)
- IBS = 5-HT mediated visceral hypersensitivity and gut motility

5HT

  • Distribution: CNS – 5% / GI tract 95%
  • Enterochromaffin cells – contain serotonin
  • Act as transducers detecting changes in chemical environment intestinal lumen
  • Releases serotonin → serotonin receptors on sensory nerves → initiate peristalsis
  • Enterocytes SERT (transporter)
  • Inactivate response
  • Stimulation of 5HT receptors on intrinsic sensory neurones → triggers peristaltic reflex and colonic mass movement
62
Q

IBS

  • symptoms
  • exam
  • diagnosis
  • management
A

THINK ABC
A - abdominal pain or discomfort
B - bloating
C - change in bowel habit

Symptoms

  • Recurrent abdominal discomfort, bloating worsens throughout day, alternate between episodes of diarrhoea and constipation
  • Good to classify as predominantly diarrhoea or constipation
  • May pass mucus; rarely have nocturnal symptoms
  • Abdominal pain may be variable – Cancer would be in one place!
  • No weight loss; overall appear well
  • Dyspepsia 87%
  • Tiredness
97%
  • Backache
79%
  • Dyspareunia 69%
  • Urinary frequency 56%
  • Headache 50%
  • Nocturia 48%; Sleep disorder 28%
  • Fibromyalgia 20%

Exam: Usually unremarkable – some tenderness to palpation

Diagnosis
- No test – diagnosis by exclusion
Only do FBC, ESR, CRP, Antibody testing for coeliac
- Absence of biological/physiological markers
- Symptoms based criteria: Rome IV
Abdominal pain and 2 of:
- Pain related to defecation
- Change in stool frequency
- Change in stool form
Symptoms over 6 months on average weekly for last 3 months

Management
Identify Patient’s Concerns
Explain nature of the condition
Reassure:
IBS is a recognised clinical entity
Involve patient:
- Symptoms can fluctuate
- Diet or stress may precipitate symptoms
Provide continuity: - ongoing review may be important to patient
- Set realistic expectations
- Symptom monitoring with diary – may help find precipitating factors

Diarrhea - 1st line = loperamide

63
Q

IBS alarm symptoms

A
Rectal bleeding
Documented weight loss or fever
Persistent diarrhoea or vomiting
Constant and recent abdominal distension
Anaemia &amp;/or GIH

New onset in patients >50 years 
Family history of bowel cancer, IBD
Frequent Nocturnal symptoms 
Absence of psychological distress
Urinary sediment - haematuria
64
Q

IBS DD

A

Food intolerance
Infection: Giardiasis, amoebiasis, TB
IBD
Bacterial overgrowth
Diveritcular disease
Colon cancer
Bile salt malabsorption
CHO malabsorption: Lactose/ fructose/ sucrose
Hormonal syndromes: Medullary thyroid cancer; Gastrinoma / Vipoma; Glucagonoma
Rarer types of colitis: Gold colitis; Collagenous / lymphocytic
Pseudo-obstruction: Myopathy / neuropathy